Most Active Stories
- Authorities Identify Victims Of Fatal Truck-School Bus Crash Downtown
- U.S. House Approves Extension Of Great Lakes Restoration Initiative
- Former CCS Data Chief Sentenced To Jail, Probation
- Nearly Two Dozen People Apply For City Council Seat
- Your Donation Can Help WCBE and Central Ohioans in Need of Food This Season!
Fri October 4, 2013
State Files New Execution Procedure
The state's new execution policy filed in federal court today would allow prisons officials to execute death row inmates with doses of a lethal injection drug prepared by specialized pharmacies, amid difficulties securing the sedative last used by the state.
The policy allows compounding pharmacies to provide future supplies of pentobarbital. The state's supply expired with the September 25th execution of Harry Mitts Junior. The new policy also establishes an alternative intravenous drug combination if expired pentobarbital is deemed unusable or if new supplies of the drug are unavailable. A federal public defender says he's reviewing the changes for any impact on federal litigation and future executions. The original manufacturer of pentobarbital, Denmark-based Lundbeck, announced in 20-11 it was making the drug off-limits to executions. That prohibition remained when the firm sold the product to Illinois-based Akorn Incorporated.